Studies how dilated cardiomyopathy and genes affect heart disease in different ethnic groups
Follows adults with dilated cardiomyopathy, a weakened heart condition, across different ethnic groups.
Key facts
- Who runs it
- University of Illinois Chicago
- Where
- Chicago, United StatesSee the site
- Trial code
- Registry title
- UIC Multi-Ethnic DCM Registry
- Status
- Recruiting
- People taking part
- 1,500 people, planned
- Started
- 11 Jul 2024
- Expected to end
- 31 Dec 2038
- Type of study
- Observational, 2 groups
- Record updated
- 28 August 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The registry is looking for adults with dilated cardiomyopathy, a heart condition where the heart cannot pump blood well. They must be admitted to or seen at a UIH site.
- Age
- 18 years or older
- Sex
- Women and men can join.
Main reasons for not taking part
- Adults who cannot give consent
- Women who are pregnant at the baseline visit
- Prisoners
- People who are not yet adults (infants, children, teenagers)
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Must be at least 18 years of age and be admitted to or seen at a UIH site
- Subjects must be willing and able to give written, informed consent
Who cannot take part
- Adults who are unable to provide consent
- Women who are pregnant at the baseline visit,
- Prisoners
- Individuals who are not yet adults (infants, children, teenagers)
Where in United States
- University of Illinois Hospital & Health SciencesChicago, United StatesContact: Yining Chen, M.S.Taking people
About the trial
What the trial wants to find out
Dilated cardiomyopathy (DCM), a condition where the heart loses its ability to pump blood throughout the body, is a common cause of death in the United States (US). It affects minorities more frequently and appears to causes greater harm than Whites. However, almost all research related to DCM has been performed in Whites, where up to half of cases run in the family. Several genes have been identified that cause the disease, but we are unsure if these same genes are also responsible for DCM in African Americans or Hispanic/Latino patients. The impact of various medical, social, and financial stressors on the severity of the disease in ethnic minorities also remains unclear. The investigators believe that certain genes are more common in different racial and ethnic groups and the greater medical, social, and financial burden faced by minorities in the US leads to more harm from DCM in these groups. The overall goal of the project is to test whether ethnic minority patients carrying genes that cause DCM experience more adverse effects in part because of various medical, social, and financial burdens. The investigators will first establish the UIC Multi-ethnic DCM Biorepository to look for how often certain genes are found across different race-ethnicity and then ask the question if these genes impact the severity of DCM. Finally, the investigators will study how a person's environment can alter the course of their disease. Through this, the investigators hope and strive to ensure equal and adequate heart care for individuals regardless of their race-ethnicity.
The 2 groups in the trial
- Dilated Cardiomyopathy
- Control
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- University of Illinois Chicago (UIC) Multi-Ethnic Dilated Cardiomyopathy (DCM) Registry
- Plain-language title
- Studies how dilated cardiomyopathy and genes affect heart disease in different ethnic groupsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 28 August 2025